JPRN-UMIN000033387已完成未知
Evaluation of glucagon secretion in type 2 diabetes - Type 2 diabetes and glucagon
agasaki University Hospital0 个研究点目标入组 23 人开始时间: 2018年7月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 23
研究概览
简要总结
The levels of plasma glucagon were elevated and peaked 30 min after the mixed meal ingestion in both type 1 diabetes and type 2 diabetes patients.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 12years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients uncontrolled fasting glucose at 80-180 mg/dL. Patients with cerebrovascular disease and/or cardiovascular disease. Pregnant women. Lactating women.
研究者
相似试验
已完成
不适用
The role of glucagon secreton for glycemic control in patients with type 1 diabetes or pancreatic diabetesType 1 diabetes, Pancreatic diabetesJPRN-UMIN000020156agasaki University Hospital34
已完成
不适用
A Crossover Study to Assess the 2 Glucose Tolerance Tests on Incretin, Beta-cell function and Insulin Sensitivity in Japanese Healthy and Type 2 Diabetes SubjectsT2DMJPRN-UMIN000014575Kansai Electric Power Hospital32
已完成
不适用
Glucagon challenge in patients with type 2 diabetes mellitus10018424DiabetesNL-OMON33022Centre for Human Drug Research16
已完成
不适用
The Role of Small Intestinal Endocrine Cells in Type 2 Diabetic HyperglucagonemiaType 2 DiabetesNCT00639613University Hospital, Gentofte, Copenhagen20
已完成
不适用
Hyperglucagonaemia in Patients With Type 2 Diabetes - Role of Glucagon ClearanceDiabetesNCT02475421University Hospital, Gentofte, Copenhagen32